BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12015196)

  • 41. Should there be an expanded role for kidney biopsy in the management of patients with type I diabetes?
    Mauer SM; Chavers BM; Steffes MW
    Am J Kidney Dis; 1990 Aug; 16(2):96-100. PubMed ID: 2382660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal failure with nephrotic syndrome: reversal with large doses of furosemide.
    Sakemi T; Uchida M; Baba N; Nagano Y; Shimokama T; Watanabe T
    Nihon Jinzo Gakkai Shi; 1991 Jan; 33(1):59-64. PubMed ID: 2038133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Contributions of renal biopsy studies to the understanding of disease.
    Seymour AE; Spargo BH; Penksa R
    Am J Pathol; 1971 Dec; 65(3):550-98. PubMed ID: 4941069
    [No Abstract]   [Full Text] [Related]  

  • 44. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etiologic variability of nephropathy in juvenile diabetes mellitus.
    Gilboa N; Durante D; McIntosh RM; Guggenheim S
    Arch Pathol Lab Med; 1979 Aug; 103(9):479-82. PubMed ID: 582380
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Focal segmental glomerulosclerosis presenting nephrotic syndrome and acute renal failure in a patient with rheumatoid arthritis].
    Sugiyama T; Sueishi M; Matsumura R; Tomioka H; Akikusa B
    Nihon Jinzo Gakkai Shi; 1997 May; 39(4):426-30. PubMed ID: 9198366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proteinuria disappears promptly after simultaneous kidney-pancreas transplantation in nephrotic diabetic patients with near-normal GFR.
    Sedlak M; Biesenbach G; Margreiter R
    Clin Nephrol; 2007 Nov; 68(5):330-4. PubMed ID: 18044267
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Idiopathic acute renal failure in nephrotic syndrome--a report of 10 cases].
    Zhang Y; Jiang Y; Wang H
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):157-60. PubMed ID: 7648934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spontaneous remission of therapy-resistant minimal change nephritis in an adult woman 12 years after onset of the disease.
    Raml A; Sedlak M; Schmekal B; Stuby U; Syre' G; Biesenbach G
    Wien Med Wochenschr; 2006 Jul; 156(13-14):421-5. PubMed ID: 16937046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severe anasarca due to beriberi heart disease and diabetic nephropathy.
    Toyonaga J; Masutani K; Tsuruya K; Haruyama N; Sugiwaka S; Suehiro T; Maeda H; Taniguchi M; Katafuchi R; Iida M
    Clin Exp Nephrol; 2009 Oct; 13(5):518-521. PubMed ID: 19459028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of acute renal failure in the elderly. Treatment options.
    Mandal AK; Baig M; Koutoubi Z
    Drugs Aging; 1996 Oct; 9(4):226-50. PubMed ID: 8894522
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversible renal failure in the nephrotic syndrome.
    Smith JD; Hayslett JP
    Am J Kidney Dis; 1992 Mar; 19(3):201-13. PubMed ID: 1553965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diabetic nephropathy: clinical and histological study in 22 patients.
    Bertoli S; Bottelli R; Confalonieri R; Radaelli L; Rovati C; Barbiano di Belgiojoso G; Micoli G
    Acta Diabetol Lat; 1983; 20(2):125-33. PubMed ID: 6880564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum cystatin C in diabetic patients. Not only an indicator for renal dysfunction in patients with overt nephropathy but also a predictor for cardiovascular events in patients without nephropathy.
    Ogawa Y; Goto T; Tamasawa N; Matsui J; Tando Y; Sugimoto K; Tomotsune K; Kimura M; Yasujima M; Suda T
    Diabetes Res Clin Pract; 2008 Feb; 79(2):357-61. PubMed ID: 17980929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
    Freedman BI; Wuerth JP; Cartwright K; Bain RP; Dippe S; Hershon K; Mooradian AD; Spinowitz BS
    Control Clin Trials; 1999 Oct; 20(5):493-510. PubMed ID: 10503809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A case of nephrotic syndrome with diabetes mellitus and primary aldosteronism].
    Mani H; Takeda K; Kiyama M; Morimoto S; Nakata T; Sasaki S; Nakagawa M
    Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):442-7. PubMed ID: 10441994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diuretics in the management of acute kidney injury: a multinational survey.
    Bagshaw SM; Delaney A; Jones D; Ronco C; Bellomo R
    Contrib Nephrol; 2007; 156():236-49. PubMed ID: 17464133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
    Mogensen CE; Christensen CK; Vittinghus E
    Diabetes; 1983 May; 32 Suppl 2():64-78. PubMed ID: 6400670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.